Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Base estimates and calculations
1.2.1 North America
1.2.2 Europe
1.2.3 Asia Pacific
1.2.4 Latin America
1.2.5 MEA
1.3 Forecast calculations
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Biosensors market industry 360° synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Device trends
2.1.3 Application trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Biosensors Industry Insights
3.1 Industry segmentation
3.2 Industry ecosystem analysis
3.2.1 Vendor Matrix
3.2.2 Distribution channel analysis
3.2.3 Profit margin trends
3.3 Raw material analysis
3.3.1 Nanomaterials
3.3.2 Polymers
3.3.3 Semiconductors
3.3.4 Others
3.3 Pricing analysis 2018 – 2032
3.3.1 Pricing analysis, by region
3.3.1.1 North America
3.3.1.2 Europe
3.3.1.3 Asia Pacific
3.3.1.4 Latin America
3.3.1.5 Middle East & Africa
3.4 Cost structure analysis
3.4.1 Component/material costs
3.4.2 Manufacturing & labour costs
3.4.3 Utilities
3.4.4 Maintenance cost
3.4.5 Finance cost
3.4.6 Administration cost
3.4.7 Others
3.5 Industry impact forces
3.5.1 Growth drivers
3.5.1.1 Growing application of biosensors in medical field
3.5.1.2 Rising prevalence of diabetes globally
3.5.1.3 High demand for portable biosensors in Asia Pacific and Europe
3.5.1.4 Technological advancements
3.5.2 Industry pitfalls & challenges
3.5.2.1 Stringent regulatory scenario
3.5.2.2 High cost of product development
3.6 Growth potential analysis
3.6.1 By type
3.6.2 By technology
3.6.3 By medical application
3.6.4 By end-use
3.7 COVID- 19 impact analysis
3.8 Regulatory landscape
3.8.1 U.S.
3.8.2 Europe
3.9 Technology landscape
3.10 Industry eco-system
3.10.1 Current trends in the industry
3.10.2 Start-up scenario
3.11 Porter's analysis
3.11.1 Bargaining power of suppliers
3.11.2 Bargaining power of buyers
3.11.3 Threat of new entrants
3.11.4 Threat of substitutes
3.11.5 Industry rivalry
3.12 PESTEL analysis
3.12.1 Political
3.12.2 Economical
3.12.3 Social
3.12.4 Technological
3.12.5 Environmental
3.12.6 Legal
Chapter 4 Competitive landscape
4.1 Introduction
4.2 Company market share, 2021
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategic outlook matrix
Chapter 5 Biosensors Market, By Type
5.1 Key type trends
5.2 Wearable biosensors
5.3 Non-wearable biosensors
Chapter 6 Biosensors Market, By Technology
6.1 Key technology trends
6.2 Electrochemical
6.3 Optical
6.4 Thermal
6.5 Piezoelectric
6.6 Others
Chapter 7 Biosensors Market, By Medical Application
7.1 Key medical application trends
7.2 Blood glucose testing
7.3 Cholesterol testing
7.4 Blood gas analysis
7.5 Pregnancy testing
7.6 Drug discovery
7.7 Infectious disease testing
7.8 Others
Chapter 8 Biosensors Market, By End-use
8.1 Key end-use trends
8.2 Point of care testing
8.3 Home healthcare diagnostics
8.4 Research laboratories
8.5 Others
Chapter 9 Biosensors Market, By Region
9.1 Key regional trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Russia
9.3.7 Switzerland
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
Chapter 10 Company Profiles
10.1 F. Hoffmann-La Roche Ltd
10.2 Abbott Laboratories
10.3 Thermo Fisher Scientific Inc.
10.4 Danaher Corporation
10.5 Siemens Healthineers AG
10.6 Ascensia Diabetes Care Holdings AG
10.7 Bio-Rad Laboratories, Inc
10.8 Biosensors International Group, Ltd
10.9 Dexcom, Inc.
10.10 LifeScan Inc.
10.11 Masimo
10.12 Nova Biomedical
10.13 Pinnacle Technology
10.14 QTL Biosystems
10.15 TE Connectivity Corporation
